Inovio Pharmaceuticals (INO) Posts Q1 Results with Data Ahead - Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Inovio Pharmaceuticals, Inc. (INO) Turns Positive
May 12, 2014 2:46 PM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) is moving along with broader markets. Shares are now positive on the session.
Following Q1 results, Inovio dropped as much as 13.4 percent to $1.87. The stock has been crawling back since just after 10am.
Shares are about 0.2 percent higher.
... MoreInovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position
May 12, 2014 6:12 AM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.41 million.
As of March 31, 2014, cash and cash equivalents plus short-term investments were $116.8 million compared with $52.6... More
